Offer - Urjas Oil for just ₹ 1 X
Methygin 0.125 Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Post Delivery Bleeding.
The optimal dosage of Methygin 0.125 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Methygin 0.125 Tablet include Headache, Abdominal Pain, Hypertension. Besides the aforementioned side effects, there are other adverse effects of Methygin 0.125 Tablet as well, which are listed below. Such side effects of Methygin 0.125 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Methygin 0.125 Tablet is Unknown for pregnant women and Unknown for women who are breastfeeding. Warnings related to Methygin 0.125 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Methygin 0.125 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. High Blood Pressure are examples of such conditions. The section on Methygin 0.125 Tablet contraindications lists all such conditions.
Additionally, Methygin 0.125 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Methygin 0.125 Tablet is considered safe while driving, and is addictive.
Methygin 0.125 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Methygin 0.125 Tablet safe for pregnant women?
Side effects of Methygin during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Methygin 0.125 Tablet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Methygin for breastfeeding women are not known.
What is the effect of Methygin 0.125 Tablet on the Kidneys?
Methygin rarely affects the kidneys.
What is the effect of Methygin 0.125 Tablet on the Liver?
Methygin may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Methygin 0.125 Tablet on the Heart?
Effects of Methygin on heart can be severe. It is not safe to use without doctor's advice.
If you are suffering from any of the following diseases, you should not take Methygin 0.125 Tablet unless your doctor advises you to do so -
Is this Methygin 0.125 Tablet habit forming or addictive?
Methygin 0.125 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Methygin 0.125 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, Methygin 0.125 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Methygin 0.125 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Methygin 0.125 Tablet
Due to a lack of research, nothing can be said about the consequences of taking Methygin 0.125 Tablet together with food.
Interaction between Alcohol and Methygin 0.125 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Methygin 0.125 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839